A feedback loop between the MEK/ERK and PI3K/AKT pathways has been demonstrated in several experimentally established EGFR-TKI-resistant NSCLC cell lines, leading to resistance to treatment with a single inhibitor of either of these signaling pathways. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.